Are giant pharmaceutical mergers good or bad for patients?
AstraZeneca is in talks with Bristol Myers Squibb about a roughly $400 billion merger, according to a Financial Times report.
Discussion (0)
Grab this poll for your site
Votes cast anywhere this poll is embedded count toward the same live total.
Sponsored
More in Business & Money
- Should a bank be allowed to shut down a customer's accounts over money-laundering concerns before any charges are filed? · 1 votes
- When you order at a restaurant, do you look at the prices or just order what you want? · 1 votes
- Would you pay extra for a premium format like IMAX, 3D, or Dolby to see a big movie in theaters? · 1 votes
- Do you check your bank balance before making a purchase? · 1 votes
Be the first to weigh in.